SciVision Biotech : Announcement of the approval for recordation being granted by FSC on extended offering period of the second domestic unsecured convertible bonds For 3 Months

 Announcement of the approval for recordation being
granted by FSC on extended offering period of the
second domestic unsecured convertible bonds For 3 Months

1.Date of occurrence of the event:2022/08/11
2.Company name:SciVision Biotech Inc.
3.Relationship to the Company (please enter "head office" or
  "subsidiaries"):Head office
4.Reciprocal shareholding ratios:N/A
5.Cause of occurrence:(1)The Company applied for extending the second
domestic unsecured convertible bonds each with a par value of NTD 100,000,
for a total amount of NTD 400,000,000.This application was approved by the
Financial Supervisory Commission per May 27, 2022 letter No.1110343177.
(2)On consideration of bigger fluctuation for domestic stock market and
better issuance timing, and following the board resolution on May 03,2022
regarding authorizing chairman to do revision when conducting the issuance
of domestic second unsecured convertible corporate bond responding to the
change of objective environment.
6.Countermeasures:To make application to FSC to extend raising period for
3 months to find the most optimized issuance timing to protect the whole
interests of the Company and shareholder equity.
7.Any other matters that need to be specified:None